Cai, J., Wei, J., Li, S., Suber, T., & Zhao, J. (2017). AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin. Mediators of inflammation, 2017(2), 6893560.

Cai, Junting, Jianxin Wei, Shuang Li, Tomeka Suber, and Jing Zhao. "AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability Through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin." Mediators of Inflammation 2017, no. 2 (2017): 6893560.

Cai, Junting, et al. "AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability Through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin." Mediators of Inflammation, vol. 2017, no. 2, 2017, p. 6893560.